Literature DB >> 11554991

Ciclopirox: an overview.

A K Gupta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11554991     DOI： 10.1046/j.1365-4362.2001.01156.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  20 in total

1.  Seborrheic dermatitis.

Authors:  Thomas Berk; Noah Scheinfeld
Journal:  P T       Date:  2010-06

2.  Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.

Authors:  Hongyu Zhou; Chaowei Shang; Min Wang; Tao Shen; Lingmei Kong; Chunlei Yu; Zhennan Ye; Yan Luo; Lei Liu; Yan Li; Shile Huang
Journal:  Biochem Pharmacol       Date:  2016-07-07       Impact factor: 5.858

3.  Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs.

Authors:  Scott J Weir; Robyn Wood; Karl Schorno; Amanda E Brinker; Prabhu Ramamoorthy; Kathy Heppert; Lian Rajewski; Mehmet Tanol; Tammy Ham; Michael J McKenna; William McCulloch; Michael Dalton; Gregory A Reed; Roy A Jensen; Michael J Baltezor; Shrikant Anant; John A Taylor
Journal:  J Pharmacol Exp Ther       Date:  2019-05-21       Impact factor: 4.030

Review 4.  Repositioning the Old Fungicide Ciclopirox for New Medical Uses.

Authors:  Tao Shen; Shile Huang
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 5.  Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.

Authors:  Agrawal Vikas; Patel Rashmin; Patel Mrunali; Rahul B Chavan; Thanki Kaushik
Journal:  AAPS PharmSciTech       Date:  2020-01-14       Impact factor: 3.246

6.  The antitumor activity of the fungicide ciclopirox.

Authors:  Hongyu Zhou; Tao Shen; Yan Luo; Lei Liu; Wenxing Chen; Baoshan Xu; Xiuzhen Han; Jia Pang; Chantal A Rivera; Shile Huang
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

Review 7.  [Mycotic infections of the anogenital region].

Authors:  P Mayser; W Hort; S Pflieger-Bruss
Journal:  Hautarzt       Date:  2005-06       Impact factor: 0.751

8.  Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.

Authors:  Markus Niewerth; Donika Kunze; Michael Seibold; Martin Schaller; Hans Christian Korting; Bernhard Hube
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Iontophoretically enhanced ciclopirox delivery into and across human nail plate.

Authors:  Jinsong Hao; Kelly A Smith; S Kevin Li
Journal:  J Pharm Sci       Date:  2009-10       Impact factor: 3.534

10.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.